Medicare Enrolled

Dr. Casey Claypool, OD

Optometrist · Spokane Valley, WA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
16010 E INDIANA AVE, Spokane Valley, WA 99216
5099288040
In practice since 2009 (16 years)
NPI: 1447480579 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Claypool from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Claypool? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Claypool

Dr. Casey Claypool is an optometrist in Spokane Valley, WA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Claypool performed 2,604 Medicare services across 1,962 unique beneficiaries.

Between the years covered by Open Payments, Dr. Claypool received a total of $244,141 from 38 pharmaceutical and/or device companies across 565 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optometrist. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Claypool is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 1% volume in WA $244,141 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,604
Medicare services
Top 1% in WA for optometrist
1,962
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~163 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
609 $64 $151
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
452 $89 $221
Eye photography
Photographic imaging of the interior structures of the eye.
421 $17 $61
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
370 $27 $111
Immunoassay substance analysis, multiple step method
A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material.
216 $11 $144
Microfluid analysis of tears
A laboratory test that analyzes tear fluid using microfluidic technology to measure specific biomarkers. This procedure helps evaluate the composition of tears for diagnostic purposes.
148 $22 $60
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
96 $120 $334
Amniotic membrane placement on eye surface
This procedure involves placing amniotic membrane on the surface of the eye to promote wound healing.
92 $1,102 $2,129
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
92 $26 $111
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
59 $46 $131
Tear duct plug insertion
A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface.
22 $108 $306
CT scan of cornea
A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye.
16 $27 $56
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
11 $75 $220
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$244,141
Total received (2018-2024)
Avg $34,877/year across 7 years
Top 0% in WA for optometrist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
565
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$168,284 (68.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$69,375 (28.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,482 (2.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$74,007
2023
$36,654
2022
$44,224
2021
$24,338
2020
$35,156
2019
$22,241
2018
$7,520

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bausch & Lomb Americas Inc.
$30,377
Tarsus Pharmaceuticals, Inc.
$17,192
BIOTISSUE HOLDINGS INC.
$16,403
SUN PHARMACEUTICAL INDUSTRIES INC.
$9,107
Johnson & Johnson Surgical Vision, Inc.
$207
Oyster Point Pharma, Inc.
$171
ABBVIE INC.
$161
Alcon Vision LLC
$138
Mallinckrodt Hospital Products Inc.
$115
Dompe US, Inc.
$49
Astellas Pharma US Inc
$34
Genentech USA, Inc.
$31
Merz Pharmaceuticals, LLC
$23
Top 3 companies account for 86.4% of 2024 payments
All-time payments by company (2018-2024) ›
Johnson & Johnson Surgical Vision, Inc.
$88,955
Bausch & Lomb Americas Inc.
$41,470
Sun Pharmaceutical Industries Inc.
$28,771
Tarsus Pharmaceuticals, Inc.
$17,192
BIOTISSUE HOLDINGS INC.
$16,403
SUN PHARMACEUTICAL INDUSTRIES INC.
$11,686
Allergan, Inc.
$11,482
ABBVIE INC.
$8,140
AbbVie Inc.
$7,278
Allergan Inc.
$5,357
Lumenis, Inc
$2,000
Glaukos Corporation
$634
Bausch & Lomb, a division of Bausch Health US, LLC
$582
BIOTISSUE HOLDINGS, INC.
$580
Mallinckrodt Hospital Products Inc.
$574
Novartis Pharmaceuticals Corporation
$477
Shire North American Group Inc
$460
Mallinckrodt Enterprises LLC
$350
Aerie Pharmaceuticals, Inc.
$308
Oyster Point Pharma, Inc.
$269
Johnson & Johnson Vision Care, Inc.
$204
Dompe US, Inc.
$178
Alcon Vision LLC
$168
RxSight Inc
$125
Mallinckrodt LLC
$108
Carl Zeiss Meditec, Inc.
$60
Merz Pharmaceuticals, LLC
$49
Thea Pharma Inc.
$48
BioTissue Holdings, Inc.
$46
Astellas Pharma US Inc
$34
Genentech USA, Inc.
$31
Regeneron Healthcare Solutions, Inc.
$26
Carl Zeiss Meditec USA, Inc.
$24
Katena Products, Inc.
$16
Horizon Therapeutics plc
$16
Ivantis, Inc
$15
TISSUETECH, INC.
$14
Sight Sciences, Inc.
$13
Top 3 companies account for 65.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALDEN SCLERAL ZENLENS · ALPHAGAN P · AMO PHACO NEEDLE · Acuvue · BESIVANCE · BLINK NUTRITEARS · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · Catalys Laser System · Cequa · DOCTORS ALLERGY FORMULA · DUREZOL · DURYSTA · EYLEA · EYSUVIS · Hydrus · IYUZEH · Izervay · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LIPIFLOW SYSTEM ACTIVATOR (DISPOSABLE) · LIPIFLOW SYSTEM ACTIVATOR II (DISPOSABLE · LOTEMAX · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · MEIBOMIAN GLAND EVALUATOR · MIEBO · OXERVATE · One Series Ultra · One Series Ultra IOL Delivery System · Oxervate · PROKERA · PROLENSA · RESTASIS · RESTASIS MULTIDOSE · Rhopressa · Rocklatan · TEARCARE SYSTEM · TEPEZZA · TYRVAYA · TearScience Activators · TearScience Lipiflow System · Tecnis 1-piece IOL · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · Tecnis Symfony IOL · VUITY · VYZULTA · Vabysmo · VisuMax · XDEMVY · XELPROS · XIIDRA · Xeomin · enVista MX60 IOL · iStent Trabecular Micro-Bypass Stent System · iStent inject Trabecular Micro-Bypass Stent System · rhopressa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (69%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optometrist and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for optometrist in WA.

Looking for an optometrist in Spokane Valley?
Compare optometrists in the Spokane Valley area by procedure volume, costs, and industry payment transparency.
Browse optometrists nearby

Geographic Context

Optometrists within 10 mi
133
Per 100K population
24.4
County median income
$73,513
Nearest hospital
MULTICARE VALLEY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Claypool is a clinical cardiology specialist, with above-average Medicare volume (top 1% in WA), with speaking/promotional industry engagement in the top 0% of WA peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Claypool experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Claypool performed 609 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Claypool receive payments from pharmaceutical companies?
Yes. Dr. Claypool received a total of $244,141 from 38 companies across 565 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Claypool's costs compare to other optometrists in Spokane Valley?
Dr. Claypool's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Claypool) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →